Inactive

The U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), has a requirement for a Transfusion-Transmissible Infection (... The U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), has a requirement for a Transfusion-Transmissible Infection (TTI) Monitoring System (TTIMS) Laboratory and Risk Factor Database Coordinating Center (LRCC). See Attachments for Solicitation, Statement of Work and related documents See Attachments for Government Responses to Contractors Questions